Integra LifeSciences IART Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$495.8M+4.0% | -$516.47M— | —— | —— | —— | ||
| $153.07M+0.8% | $151.83M+0.6% | $150.99M+1.7% | $148.43M+0.6% | $147.52M+4.7% | ||
| $21.88M+17.7% | $18.58M-6.6% | $19.9M+6.4% | $18.7M-9.4% | $20.65M-15.3% | ||
| $71.44M+41.8% | $50.38M-43.6% | $89.31M+26.0% | $70.89M-30.8% | $102.37M-20.9% | ||
| $67.36M-17.3% | $81.44M-13.2% | $93.82M-13.4% | $108.31M-8.1% | $117.87M+12.9% | ||
| -$86.99M+19.5% | -$108.06M-39.6% | -$77.41M-7.2% | -$72.21M+80.6% | -$372.76M+4.6% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Integra LifeSciences generate?
- Integra LifeSciences (IART) generated $71.4M in operating cash flow over the trailing twelve months.
- What is Integra LifeSciences's free cash flow?
- After $67.4M of capital expenditures, Integra LifeSciences's free cash flow was -$61.8M over the trailing twelve months, down 193.2% year over year.
- Where does Integra LifeSciences's cash flow data come from?
- Every line is extracted from Integra LifeSciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
